Seasoned policy and public health leader will lead DC-based advocacy coalition focused on advancing global health innovation.
In advance of the 154th session of the World Health Organization Executive Board meeting, GHTC is calling on policymakers to take urgent actions to accelerate health research to address immunization gaps, tuberculosis, neglected tropical diseases, and antimicrobial resistance.
Sen. Van Hollen, Rep. Fitzpatrick, and Cabotegravir Long Acting for HIV Prevention honored with GHTC Innovating for Impact Awards
At GHTC's seventh annual Innovating for Impact Awards, Senator Chris Van Hollen and Congressman Brian Fitzpatrick received Congressional Champion Awards, and the partners, led by ViiV Healthcare, that developed and are accelerating global access to cabotegravir long acting (CAB-LA) for HIV prevention received the Partnership Award.
Congressman Brian Fitzpatrick (PA-01), Congresswoman María Elvira Salazar (FL-27), and Congresswoman Chrissy Houlahan (PA-06) introduced the Supporting Innovative Global Health Technologies (SIGHT) Act of 2023, which would establish a disease-agnostic research and development program at the US Agency for International Development, in the House of Representatives.